WallStSmart

Nomura Holdings Inc ADR (NMR)vsPJT Partners Inc (PJT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 123524% more annual revenue ($2.33T vs $1.89B). NMR leads profitability with a 17.3% profit margin vs 10.6%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 84/100 (A-).

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

PJT

Strong Buy

68

out of 100

Grade: B-

Growth: 8.7Profit: 8.5Value: 5.7Quality: 7.5
Piotroski: 5/9Altman Z: 3.08

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

PJT5 strengths · Avg: 8.8/10
Return on EquityProfitability
68.4%10/10

Every $100 of equity generates 68 in profit

Altman Z-ScoreHealth
3.0810/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

Revenue GrowthGrowth
19.5%8/10

19.5% revenue growth

EPS GrowthGrowth
37.5%8/10

Earnings expanding 37.5% YoY

Areas to Watch

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

PJT2 concerns · Avg: 3.5/10
Price/BookValuation
13.4x4/10

Trading at 13.4x book value

Debt/EquityHealth
1.343/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bull Case : PJT

The strongest argument for PJT centers on Return on Equity, Altman Z-Score, Operating Margin. Revenue growth of 19.5% demonstrates continued momentum. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Bear Case : PJT

The primary concerns for PJT are Price/Book, Debt/Equity.

Key Dynamics to Monitor

PJT carries more volatility with a beta of 0.83 — expect wider price swings.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 68/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

PJT Partners Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

PJT Partners Inc., an investment bank, provides a variety of shareholder, restructuring and special situations, and capital market advisory services to corporations, financial backers, institutional investors and governments worldwide. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?